The Prague Post - neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

EUR -
AED 4.27842
AFN 79.494691
ALL 97.349401
AMD 446.812545
ANG 2.084672
AOA 1068.137432
ARS 1532.17935
AUD 1.784886
AWG 2.099582
AZN 1.984813
BAM 1.956408
BBD 2.35013
BDT 141.413924
BGN 1.955838
BHD 0.436
BIF 3470.67801
BMD 1.164817
BND 1.495765
BOB 8.042498
BRL 6.32927
BSD 1.163962
BTN 101.918656
BWP 15.66073
BYN 3.842894
BYR 22830.409242
BZD 2.338026
CAD 1.602031
CDF 3366.320968
CHF 0.94157
CLF 0.028776
CLP 1128.882661
CNY 8.365137
CNH 8.374014
COP 4710.519131
CRC 589.78319
CUC 1.164817
CUP 30.867645
CVE 110.29926
CZK 24.442055
DJF 207.0117
DKK 7.468228
DOP 71.082078
DZD 150.227409
EGP 56.111766
ERN 17.472252
ETB 161.509866
FJD 2.623522
FKP 0.867226
GBP 0.865906
GEL 3.149503
GGP 0.867226
GHS 12.279814
GIP 0.867226
GMD 84.453703
GNF 10093.13498
GTQ 8.930774
GYD 243.516683
HKD 9.143585
HNL 30.477466
HRK 7.54033
HTG 152.297304
HUF 395.54894
IDR 18935.378351
ILS 3.998246
IMP 0.867226
INR 102.186757
IQD 1524.773603
IRR 49067.908029
ISK 143.074897
JEP 0.867226
JMD 186.357884
JOD 0.825901
JPY 171.994565
KES 150.498758
KGS 101.863677
KHR 4662.408141
KMF 491.727858
KPW 1048.401035
KRW 1617.651423
KWD 0.355887
KYD 0.970014
KZT 629.005372
LAK 25182.821914
LBP 104288.692604
LKR 350.05873
LRD 233.374491
LSL 20.631208
LTL 3.439402
LVL 0.704587
LYD 6.31096
MAD 10.540574
MDL 19.541902
MGA 5136.595453
MKD 61.541171
MMK 2445.355161
MNT 4171.903575
MOP 9.410763
MRU 46.428421
MUR 52.894772
MVR 17.942534
MWK 2018.335569
MXN 21.643815
MYR 4.939263
MZN 74.502122
NAD 20.631208
NGN 1784.83757
NIO 42.833304
NOK 11.985889
NPR 163.06965
NZD 1.955966
OMR 0.444652
PAB 1.163962
PEN 4.11978
PGK 4.909525
PHP 66.10379
PKR 330.266983
PLN 4.248949
PYG 8717.707765
QAR 4.254221
RON 5.073131
RSD 117.596454
RUB 92.486284
RWF 1683.64463
SAR 4.371747
SBD 9.571376
SCR 16.475752
SDG 699.476769
SEK 11.155782
SGD 1.497377
SHP 0.915363
SLE 26.911539
SLL 24425.630445
SOS 665.200904
SRD 43.42325
STD 24109.355964
STN 24.507612
SVC 10.184163
SYP 15145.286158
SZL 20.623406
THB 37.511348
TJS 10.871223
TMT 4.088507
TND 3.41346
TOP 2.728122
TRY 47.38777
TTD 7.90059
TWD 34.836297
TZS 2894.570133
UAH 48.148355
UGX 4153.290033
USD 1.164817
UYU 46.704507
UZS 14658.553022
VES 149.967542
VND 30547.32053
VUV 140.171895
WST 3.103261
XAF 656.160807
XAG 0.030342
XAU 0.000343
XCD 3.147976
XCG 2.097752
XDR 0.815486
XOF 656.160807
XPF 119.331742
YER 280.080622
ZAR 20.668281
ZMK 10484.753138
ZMW 26.974378
ZWL 375.070534
  • RBGPF

    -4.1600

    71.84

    -5.79%

  • RYCEF

    -0.1000

    14.35

    -0.7%

  • CMSC

    0.0900

    23.05

    +0.39%

  • NGG

    -1.0700

    71.01

    -1.51%

  • BTI

    0.5500

    57.24

    +0.96%

  • SCU

    0.0000

    12.72

    0%

  • RELX

    -1.0566

    48

    -2.2%

  • GSK

    0.2200

    37.8

    +0.58%

  • VOD

    0.1000

    11.36

    +0.88%

  • CMSD

    0.0600

    23.58

    +0.25%

  • JRI

    0.0250

    13.435

    +0.19%

  • SCS

    -0.1200

    15.88

    -0.76%

  • RIO

    1.0900

    61.86

    +1.76%

  • AZN

    -0.5050

    73.55

    -0.69%

  • BCC

    -1.1000

    82.09

    -1.34%

  • BCE

    0.5700

    24.35

    +2.34%

  • BP

    -0.0500

    34.14

    -0.15%

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare group AG, a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

Text size:

neurocare group AG ("neurocare" or the "Company"), a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

neurocare appoints Kevin Reeder as CFO starting January 2025

Kevin Reeder holds an MBA from Oxford University and is currently the CEO of the venture capital firm bm|t, one of neurocare´s largest investors. Kevin has a long history in international investment management both in the US and in Europe, spanning venture capital, private equity, and publicly traded investments.

Prior to joining bm|t, Kevin held key roles at INVESCO, Silvergate Capital, GVO Asset Management, and Bank am Bellevue. He also gained experience outside of the investment sector as Head of Data and Credit at M-KOPA, a high-growth company in Africa, where he led fundraising efforts, managed financial operations, and established the company's data analytics platform.

Kevin joined the neurocare board at the end of 2021 and played a key role in fundraising, strategy, and M&A. He will step aside from the board to fully focus on his responsibilities as CFO, driving financial strategy and supporting neurocare's growth initiatives.

"We are delighted to welcome Kevin Reeder as neurocare's new CFO. Having worked with Kevin since joining the board, I have developed a deep respect and admiration for him as a business leader who understands our business and vision. Kevin's exceptional expertise and longstanding familiarity with neurocare's goals make him an ideal fit to help drive our growth and deliver value to our stakeholders," said Tristan de Boysson, Chairman of the Supervisory Board.

"Kevin's appointment as CFO completes neurocare's Global Leadership Team at a time of such exciting growth for our innovative company," said Thomas Mechtersheimer, Founder & CEO of neurocare. "Having worked closely with Kevin as a Board member, I am confident that his deep understanding of our business will enable us to drive neurocare's growth faster right away. On a personal note, I am much looking forward to sharing my life's professional vision and purpose with someone so energetic and equally purpose driven."

"I am honored to step into the role of CFO at neurocare and to be part of such a forward-thinking company dedicated to transforming mental health and performance," said Kevin Reeder. "Having had the privilege of working with neurocare as a Board member, I have a deep appreciation for the team's vision and the positive impact we're making. I look forward to leveraging my experience to support neurocare's growth and financial strategy as we continue to expand our reach and become a global leader in mental healthcare."

Contact Information:

Sally Remington
Global Marketing Manager
[email protected]
+49 152 2305 8385

SOURCE: neurocare group AG

U.Pospisil--TPP